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Abstract
Background: Peripheral blood mononuclear cells (PBMCs) are relatively easily obtainable cells in
humans. Gene expression profiles of PBMCs have been shown to reflect the pathological and
physiological state of a person. Recently, we showed that the nuclear receptor peroxisome
proliferator-activated receptor alpha (PPARα) has a functional role in human PBMCs during fasting.
However, the extent of the role of PPARα in human PBMCs remains unclear. In this study, we
therefore performed gene expression profiling of PBMCs incubated with the specific PPARα ligand
WY14,643.
Results: Incubation of PBMCs with WY14,643 for 12 hours resulted in a differential expression of
1,373 of the 13,080 genes expressed in the PBMCs. Gene expression profiles showed a clear
individual response to PPARα activation between six healthy human blood donors. Pathway
analysis showed that genes in fatty acid metabolism, primarily in β-oxidation were up-regulated
upon activation of PPARα with WY14,643, and genes in several amino acid metabolism pathways
were down-regulated.
Conclusion: This study shows that PPARα in human PBMCs regulates fatty acid and amino acid
metabolism. In addition, PBMC gene expression profiles show individual responses to WY14,643
activation. We showed that PBMCs are a suitable model to study changes in PPARα activation in
healthy humans.
Background
The function of the nuclear receptor peroxisome prolifer-
ator-activated receptor alpha (PPARα) has been studied
extensively from the time of its discovery in the early
1990s [1]. PPARα is a ligand activated nuclear receptor,
which is known to be activated by free fatty acids and their
derivatives [2,3]. Besides fatty acids, several synthetic
compounds are available that specifically activate PPARα,
including hypolipidemic drugs, such as fibrates and piri-
nixic acid (WY14,643) [4]. Synthetic PPARα agonists
mimic effects of dietary unsaturated fatty acids on hepatic
gene expression in terms of regulation of target genes and
molecular mechanism [5]. Activation of PPARα with
WY14,643 in mice showed that the main function of
PPARα in liver is the regulation of lipid metabolism, and
more specifically fatty acid β-oxidation [6]. PPARα was
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also found to be involved in regulation of amino acid
metabolism [7] and inflammation [8,9]. In humans, the
function of PPARα is examined less thoroughly, because
functional studies are more complicated. There is no
human genetic disease linked to a dysfunctional PPARα
gene and tissue sampling is often not feasible in healthy
volunteers. Blood is one of the few tissues which is readily
available in healthy humans. Peripheral blood mononu-
clear cells (PBMCs) are relatively easily obtainable by iso-
lation from blood. These cells consist of lymphocytes and
monocytes/macrophages and it is known that PPARα is
expressed in these cells [10,11]. The use of PBMCs has
proven to be highly robust in distinguishing a disease
state from healthy state, by studying gene expression pro-
files of these cells [12,13]. Recently, we showed that
PBMC gene expression profiles of healthy volunteers can
also reflect changes between 24 and 48 hours fasting,
when plasma fatty acid concentrations are elevated. In
addition, we showed that PPARα seems to have a func-
tional role in human PBMC during fasting as several of the
genes changed upon fasting were also changed upon incu-
bation of PBMC with the specific PPARα agonist
WY14,643 [14]. However, the extent of the role of PPARα
in human PBMCs remains unclear. Therefore, we tried to
elucidate the function of PPARα in human PBMCs by
whole genome microarray analysis of the PBMCs incu-
bated with the specific PPARα ligand WY14,643. Further-
more, to examine the complete role of PPARα within
PBMCs during fasting, we compared microarray analysis
of PBMCs activated with WY14,643, with microarray anal-
ysis of PBMCs during 24 hours of fasting.
Results
PPARα regulation in PBMCs after incubation with 
WY14,643
Incubation of PBMC with the specific PPARα ligand
WY14,643 for 12 hours resulted in a differential expres-
sion of 1,373 of the 13,080 genes expressed in the PBMCs,
indicating a PPARα-dependent regulation of 10.5% of the
genes expressed in PBMC (Figure 1). More than half of
these genes (56%) were up-regulated. Pathway analysis of
the genes changed upon activation of PPARα with
WY14,643, showed a marked increase in fatty acid metab-
olism, primarily in β-oxidation, and a decrease in several
amino acid metabolism pathways (data not shown).
A peroxisome proliferator response elements (PPREs) was
ascribed to 106 out of the 1,373 genes changed, using the
study of Lemay et al [15]. Of these genes, 75 were up-reg-
ulated and 31 were down-regulated (Figure 2). Figure 2
shows the responses to activation of PPARα for each per-
son by illustrating the changes in gene expression of these
106 genes per individual. For several genes a clear varia-
tion in response upon PPARα activation between individ-
uals is present. Donor B and, especially, donor E show an
obvious distinction from the other donors. However, no
difference could be found in the expression of PPARα
between the donors at basal level, and also after incuba-
tion with WY14,643 no change in expression of PPARα
was observed (data not shown). Another reason for the
variation could be the difference in concentration of the
PPARα ligands, i.e. fatty acids, and other nutritional fac-
tors present in the blood during donation. Blood donors
are commonly advised to eat before donating blood. To
investigate whether the nutritional status influences
changes in gene expression, we incubated PBMCs of four
volunteers, obtained after a meal and after an overnight
fast, with WY14,643. Using QPCR, we determined the
changes in PBMC gene expression of genes that showed
either a low (PDK4, SLC25A20, ACAA2) or a high varia-
Gene selection procedure after microarray analysis of  WY14,643 incubated PBMCs Figure 1
Gene selection procedure after microarray analysis 
of WY14,643 incubated PBMCs. Flow chart of the fol-
lowed gene selection procedure after microarray analysis of 
WY14,643 incubated PBMCs from 6 donors. PPRE; number 
of genes containing a peroxisome proliferator response ele-
ment according to Lemay et al.BMC Genomics 2008, 9:262 http://www.biomedcentral.com/1471-2164/9/262
Page 3 of 9
(page number not for citation purposes)
Genes changed after incubation with WY14,643, containing a predicted or reported PPRE Figure 2
Genes changed after incubation with WY14,643, containing a predicted or reported PPRE. Heatmap of the signal 
log ratio of genes changed upon incubation with WY14,643 that contained a predicted or reported PPRE. Red indicates up-reg-
ulation compared to the vehicle incubated PBMCs and green indicates down-regulation. SL R, signal log ratio; PPRE, peroxi-
some proliferator response elementBMC Genomics 2008, 9:262 http://www.biomedcentral.com/1471-2164/9/262
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tion (CPT1, ABCA1, TLR4, PPARγ) between donors in the
microarray analyzes of the first study (Figure 3). No signif-
icant differences were observed in gene expression
between the fasted and postprandial state.
To analyze whether the genes that did not have a PPRE
according to Lemay et al. might have other transcriptional
binding sites, a network analysis and a subsequent tran-
scription factor binding site search with Genomatix soft-
ware was performed. The network analysis showed that,
besides the transcription factor PPAR, the transcription
factors NFkB, JUN, TP53, SP1 and CTNNB1 were also
directly linked to at least 10 genes from the list of 1,373
genes, The subsequent search for binding sites resulted in
an additional 122 genes that could be linked to a PPRE
and revealed that another 371 genes could be linked to at
least one of the other selected transcription factors (see
Additional file 1).
To obtain a selection of robust responding genes upon
activation of PPARα with WY14.643, genes were selected
that were more than 10% up or down regulated in all
donors. This resulted in a list of 58 genes, including sev-
eral known PPARα target genes (ADFP, PDK4, SLC25A20)
(Figure 4), with a main function in fatty acid β-oxidation.
Remarkably, only 16% of the genes in this list contained
a predicted or reported PPRE.
To validate our data observed with microarray analyzes a
selection of genes changed in the microarray analyzes was
also measured with quantitative real time PCR (Q-PCR).
In concordance with our microarray results, Q-PCR ana-
lyzes resulted in similar changes in expression of all genes
analyzed (Figure 5).
PPARα regulation in PBMCs during fasting
Figure 6 shows the genes changed upon 24 hours fasting
in healthy human volunteers with the number of genes
that contain a PPRE. Comparison of gene expression pro-
files of PBMCs incubated with the PPARα ligand
WY14,643 and fasted for 24 hours resulted in an overlap
of 238 genes, indicating that around 14% of the genes
changed during fasting are regulated by PPARα (Figure 7).
Pathway analysis showed that these 238 genes were pri-
marily involved in fatty acid metabolism. We found no
overlap in pathways involved in amino acid metabolism.
Exploration of the genes involved in fatty acid metabo-
lism showed that fatty acid β-oxidation was specifically
regulated, both in WY14,643 incubated cells and in
PBMCs isolated after fasting (data not shown)
Discussion
In the present study, we showed that activation of the
nuclear receptor PPARα in peripheral blood mononuclear
cells results in a considerable change in gene expression
profiles, as 10.5% of the genes expressed exhibited altered
gene expression levels after incubation with the specific
PPARα agonist WY14,643. The main function of PPARα
in PBMCs appeared to be the regulation of fatty acid β-oxi-
dation and other lipid metabolism related functions,
which is in line with results from mice studies in liver [16]
and intestine [17], and human cell line studies [18,19].
Moreover, the observed down-regulation of amino acid
metabolism has been shown before in liver in studies
comparing wild type mice to the PPARα knock out mouse
model [7].
Besides the possible roles of PPARα in PBMCs, this study
also demonstrates strong individual variability between
the subjects in gene expression responses to activation
with WY14,643. It appears that each donor has its own
specific gene expression profile response to PPARα activa-
tion, which results in distinct differences in the expression
of certain genes after WY14,643 incubation. Beck et al.
also reported differences in responsiveness in gene expres-
sion between individuals, after incubation of endothelial
cells with LPS. However, endothelial cell cultures were
already divided beforehand into type I or type II respond-
ers based on their LPS mediated IL8 production [20]. In
another study, incubation of cultured macrophages with
Gene expression changes of PBMCs incubated with  WY14,643 isolated postprandial or after an overnight fast Figure 3
Gene expression changes of PBMCs incubated with 
WY14,643 isolated postprandial or after an overnight 
fast. Mean gene expression changes of PBMCs incubated 
with WY14,643, isolated postprandial or after an overnight 
fast. Error bars indicate standard deviations. PDK4, Pyruvate 
dehydrogenase kinase 4; SLC25A20, carnitine-acylcarnitine trans-
locase; ACAA2, acetyl-Coenzyme A acyltransferase 2; CPT1, Carni-
tine palmitoyltransferase 1; ABCA1, ATP binding cassette 
transporter 1; TLR4, Toll-like receptor-4; PPARγ, peroxisome prolif-
erator-activated receptor gamma.BMC Genomics 2008, 9:262 http://www.biomedcentral.com/1471-2164/9/262
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oxidized low-density lipoprotein resulted in a person-spe-
cific inflammatory gene expression response that could be
correlated to changes in gene expression of scavenger
receptors [21]. However, we did not find a correlation
between basal PPARα  expression or changes in PPARα
expression and the observed variation in gene expression
changes. In addition, the differences observed are proba-
bly not caused by the nutritional status of the subjects at
baseline, as we did not observe differences in expression
changes of selected PPARα target genes between the post-
prandial and the fasted state of PBMCs incubated with
WY14,643. However, it should be noted here that only
four subjects were studied. A reason for the difference in
response of the donors in the first study could be genetic
variation, such as single nucleotide polymorphisms
(SNPs) in the PPARα gene, its target genes or PPARα co-
factors involved in activation of gene transcription. Fur-
thermore, epi-genetic variation such as methylation status
Genes changed more than 10% in all individuals after incubation with WY14,643 Figure 4
Genes changed more than 10% in all individuals after incubation with WY14,643. Heat map of genes changed more 
than 10% in all individuals after incubation with WY14,643. Red indicates up-regulation and green indicates down-regulation. 
SLR, signal log ratio; PPRE, peroxisome proliferator response elementBMC Genomics 2008, 9:262 http://www.biomedcentral.com/1471-2164/9/262
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of the PPARα promoter or its target genes may have
caused between-subject differences in gene expression lev-
els. Additional studies are required to elucidate whether
gene expression profiles can be clustered in different
response profiles, simplifying the identification of factors
responsible for these individual responses. With respect to
personalized nutrition these individual responses are of
great interest as it can be expected that nutrients such as
fatty acids can induce similar variations in response as
WY14,643, which in the end might lead to personalized
dietary advice.
The PPRE analyzes of the genes changed showed that
approximately 8% of the genes changed after incubation
with the PPARα ligand WY14,643 contained a predicted
or reported PPRE, using the list as described by Lemay et
al [15]. However, Lemay et al. report that they tolerate a
low false-positive, and a high (60%) false-negative rate,
suggesting that their list of PPREs is far from complete.
Our additional transcription factor binding site analysis
increase the number of genes that contain a PPRE to a
total of 17% of the genes changed. A network search
showed that, besides PPAR, five other transcription factors
were involved in direct regulation of at least 10 out of the
1,373 changed genes. Interestingly, all these transcription
factors are known to be affected by PPARα activation [22-
26]. Transcription factor binding site analysis revealed
that, out of the changed genes that did not contain a
PPRE, 27% contained a binding site for at least one of the
other five selected transcription factors These genes
appear not to be regulated by PPARα directly, but indi-
rectly, via these other transcription factors, a mechanism
which has been suggested before [27,28]. The role of
PPARα in this respect seems to be extensively larger than
expected based on the outcome of PPRE analyzes alone.
An interesting observation is the decrease in expression
level of genes containing a PPRE. Activation of PPARα by
a ligand may result in a negative regulation of genes by
Gene selection procedure after microarray analysis of PBMC  of three 24 hour fasted subjects Figure 6
Gene selection procedure after microarray analysis 
of PBMC of three 24 hour fasted subjects. Flow chart 
of the followed gene selection procedure after microarray 
analysis of PBMC of three 24 hour fasted subjects. PPRE; 
number of genes containing a peroxisome proliferator 
response element according to Lemay et al. Data from this 
fasting study was published previously [14], but has been 
used here after applying a different annotation procedure.
Comparison of microarray and quantitative real time PCR  analysis Figure 5
Comparison of microarray and quantitative real time 
PCR analysis. Mean gene expression changes of microarray 
and quantitative real time PCR analysis (Q-PCR) of six genes 
after incubation with WY14,643. Error bars indicated stand-
ard deviations. PDK4, Pyruvate dehydrogenase kinase 4; 
ACADVL, acyl-Coenzyme A dehydrogenase, very long chain ; 
ABCA1, ATP binding cassette transporter 1; SLC25A20, carnitine-
acylcarnitine translocase; ACAA2, acetyl-Coenzyme A acyltrans-
ferase 2.BMC Genomics 2008, 9:262 http://www.biomedcentral.com/1471-2164/9/262
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means of transrepression as has been reported in several
studies and reviewed by Ricote and Glass (2007) [29].
This transrepression, however, does not require the pres-
ence of PPREs in the promoter regions of the target genes.
Apparently, negative regulation of these genes, regardless
of its mechanism, is stronger than the transcriptional acti-
vation of PPARα. Previously, Degenhardt et al. (2006)
also showed down regulation of an insulin-like growth
factor-binding protein gene (IGFBP-6) that contained a
predicted PPRE, in response to the presence of a PPARα
ligand [30].
The overlap in gene expression profiles between fasting
and incubation with WY14,643 shows that PPARα in
PBMCs carries out a substantial part of its function during
fasting, when concentrations of its natural ligands, free
fatty acids, are elevated in the blood. The main role of
PPARα in PBMCs during fasting is fatty acid β-oxidation,
most likely to cope with the reduced availability of glu-
cose for utilization in energy production and the increase
of fatty acids.
Direct comparison between the two array analysis should
be examined with care, since the two studies are distinctly
different in set-up. The fasting intervention study was con-
ducted in vivo, while the WY14,643 incubation experi-
ments were performed ex vivo. Moreover, fasting involves
many more changes in physiology, apart from the before-
mentioned increase in plasma free fatty acids, including
changes in plasma insulin, glucose and leptin concentra-
tions. The PPARα ligand incubations were set-up to eluci-
date the specific effects of activation of one nuclear factor,
controlling for all other parameters.
Summarizing, this study gives us valuable information on
the extent of the effect of PPARα activation, during fasting
and in general, on human PBMC gene expression. It also
shows that persons respond differently to PPARα activa-
tion with respect to their gene expression changes, indicat-
ing a possible person-specific nutrient response. It seems
justified to conclude that human PBMCs are a suitable
model to study changes in PPARα activation. This opens
up the possibilities for more specific PPARα signaling
studies in healthy humans using these relatively easily
obtainable blood cells.
Methods
PBMC incubation
PBMCs from six healthy Caucasian male blood donors,
aged between 30 and 48 yr, were isolated directly after
arrival of the buffy coat (max. 8 hours after donation) by
Ficol-paque Plus density gradient centrifugation (Amer-
sham Biosciences, Roosendaal, the Netherlands). PBMCs
were incubated in RPMI1640 medium with 2 mmol/L L-
glutamine, 10% fetal bovine serum and antibiotics (peni-
cillin and streptomycin) in the presence of 5% CO2 at
37°C. at 1.0 × 106 cells per ml with either WY14,643 (50
μM) or vehicle (DMSO, 0.1%) for 12 hours. All donors
gave full written informed consent.
Pre- vs. postprandial incubation
PBMCs of four healthy volunteers, aged between 28 and
34, were isolated after a meal and after an overnight fast.
PBMCs were incubated at 1.0 × 106 cells per ml with either
WY14,643 (50 μM) or vehicle (DMSO, 0.1%) for 12
hours. All volunteers gave full written informed consent.
Statistical methods
A 2-tailed paired t test was used to determine significant
differences in Q-PCR gene expression values between the
postprandial and the fasted state. Statistical significance
was accepted at p 0.05. All calculations were performed
with the use of the SPSS (version 12.0.1; SPSS, Chicago,
IL).
Microarray processing
For 6 donors of the incubation experiments, total RNA
from PBMCs was labeled using a one-cycle cDNA labeling
kit (Affymetrix Inc, Santa Clara, CA) and hybridized to
Affymetrix Human whole genome U133 plus 2.0 arrays
(Affymetrix). Sample labeling, hybridization to chips and
image scanning was performed according to the manufac-
turer's GeneChip Expression Analysis Technical Manual
(Affymetrix).
Intervention study
For comparison of microarray data of the abovemen-
tioned incubation study, with microarray data of PBMC of
fasted volunteers, we used the earlier described microarray
Overlap between genes changed upon WY14,643 incubation  and after 24 hours fasting Figure 7
Overlap between genes changed upon WY14,643 
incubation and after 24 hours fasting. Venn diagram of 
overlap between genes changed upon WY14,643 incubation 
and after 24 hours fasting.BMC Genomics 2008, 9:262 http://www.biomedcentral.com/1471-2164/9/262
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data of a 48 hours fasting study [14]. Briefly, four healthy
male Caucasian volunteers, between 19 and 22 year of age
were fasted for 48 hours. PBMCs were isolated out of
blood taken at baseline, after 24 hours and after 48 hours
of fasting. All volunteers gave full written informed con-
sent and the study protocol was approved by the medical
ethics committee of Wageningen University.
Microarray analysis
Microarrays were analyzed using the reorganized oligonu-
cleotide probes as described by Dai et al (2005) [31]. Dai
et al. combined all individual probes for a gene, enabling
the possibility to detect the overall transcription activity of
a gene, based on the latest genome and transcriptome
information, instead of the Affymetrix probe set annota-
tion. Application of this annotation procedure on the pre-
viously published data from the 48 hours fasting study
[14] resulted in a difference in number of genes expressed
and changed as compared to the previously used annota-
tion method as this analysis was performed on probe set
level.
Expression values were calculated using the Robust Multi-
chip Average (RMA) method. RMA signal value estimates
are based on a robust average of background corrected
perfect match intensities and normalization was per-
formed using quantile normalization [32,33]. Only genes
with normalized signals higher then 20 on at least two out
of twelve arrays were defined as expressed and selected for
further analysis. Genes were defined as 'changed' when
comparison of the normalized signal intensities showed a
p-value lower then 0.05 in a two-tailed paired t test with
Bayesian correction (Limma) [34]. Pathway analysis was
performed using Ingenuity Pathway Analysis 5.5 (Ingenu-
ity Systems). Array data have been submitted to the Gene
Expression Omnibus, accession number GSE11289.
PPRE incidence
To indicated which of the genes changed upon activation
of PPARα had a predicted or reported peroxisome prolif-
erator response element (PPRE), we used information
from Lemay et al. [15]. This paper recently reported pre-
dicted PPRE on a genome wide scale, using computational
genomics and also summarized known PPRE. Using
Genomatix software [35], network analysis was per-
formed on 1,373 genes in BiblioSphere, from which tran-
scription factors were selected that were directly linked to
more than 10 genes from our list of changed genes. Sub-
sequent transcription factor binding site analysis identi-
fied transcription factor binding sites in the promoters of
our genes of interest that were cocited at least once in an
abstract with these transcription factors. Heat maps were
created by using Spotfire software.
cDNA synthesis and quantitative real-time PCR
RNA was reverse transcribed with the use of the cDNA syn-
thesis kit (Promega, Leiden, the Netherlands). Standard
quantitative real-time polymerase chain reaction (Q-PCR)
was performed with the use of Platinum Taq DNA
polymerase and SYBR Green on an iCycler PCR machine
(Bio-Rad Laboratories BV) and duplicated at least twice.
Primer sequences used in the PCRs were chosen based on
the sequences available in PRIMERBANK [36]. Q-PCR
data were normalized by measuring cycle threshold ratios
between candidate genes and a housekeeping gene,
human acidic ribosomal phosphoprotein PO, which was
shown to be consistent within PBMCs [37].
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